Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)
The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs).
| From | National Institutes of Health |
|---|---|
| Who can apply | state governments, counties, cities and townships, special districts (water, fire, parks, etc.), school districts, public colleges and universities and 9 more types |
| Eligibility notes | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or… |
| How much | up to $150K per award; $150K total |
| Deadline | Wed, Aug 11, 2027 (292 days left) |
| Category | Education, Health |
| Type | Grant |
| Opportunity # | PAR-25-101 |
| Assistance listing | 93.279 |
| Posted | Mon, Dec 30, 2024 |